7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		               
      cash flows from operating activities
    		               
      net income
    		1,483,000,000 566,000,000 742,000,000 451,000,000 1,171,000,000 1,151,000,000 -791,000,000 496,000,000 1,477,000,000 -556,000,000 -290,000,000 -572,000,000 -44,000,000 1,242,000,000 1,565,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		               
      realized investment (gains) losses
    		1,026,000,000 1,699,000,000 730,000,000 1,844,000,000 166,000,000 308,000,000 2,402,000,000 938,000,000 -217,000,000 1,392,000,000 514,000,000 1,147,000,000 316,000,000 -878,000,000 -432,000,000 
      change in value of market risk benefits, net of related hedging (gains) losses
    		-324,000,000 426,000,000 351,000,000 146,000,000 297,000,000 -123,000,000 251,000,000 -16,000,000 -75,000,000       
      policy charges and fee income
    		-504,000,000 -502,000,000 -507,000,000 -554,000,000 -557,000,000 -571,000,000 -553,000,000 -533,000,000 -540,000,000 -617,000,000 -581,000,000 -700,000,000 -634,000,000 -572,000,000 -588,000,000 
      interest credited to policyholders’ account balances
    		1,582,000,000 1,138,000,000 825,000,000 863,000,000 1,102,000,000 1,283,000,000 872,000,000 1,149,000,000 981,000,000 779,000,000 703,000,000 665,000,000 169,000,000 723,000,000 917,000,000 
      depreciation and amortization
    		-144,000,000 482,000,000 -161,000,000 -41,000,000 -26,000,000 397,000,000 -45,000,000 5,000,000 41,000,000 62,000,000 -126,000,000 170,000,000 18,000,000 117,000,000 42,000,000 
      (gains) losses on assets supporting experience-rated contractholder liabilities
    		-364,000,000 -218,000,000 256,000,000 166,000,000 -138,000,000 -356,000,000 -4,000,000 -288,000,000 -134,000,000 28,000,000 20,000,000 108,000,000 972,000,000 132,000,000 78,000,000 
      change in:
    		               
      deferred policy acquisition costs
    		-297,000,000 -282,000,000 -375,000,000 -268,000,000 -241,000,000 -273,000,000 -215,000,000 -180,000,000 -205,000,000 -45,000,000 -47,000,000 58,000,000 266,000,000 -164,000,000 -120,000,000 
      future policy benefits and other insurance liabilities
    		2,550,000,000 294,000,000 -205,000,000 875,000,000 -524,000,000 4,175,000,000 1,991,000,000 850,000,000 1,888,000,000 170,000,000 2,309,000,000 2,690,000,000 1,404,000,000 1,983,000,000 3,116,000,000 
      reinsurance related-balances
    		-445,000,000 -652,000,000 -601,000,000             
      income taxes
    		400,000,000 -768,000,000 133,000,000 127,000,000 -187,000,000 203,000,000 -86,000,000 -553,000,000 357,000,000 -248,000,000 -66,000,000 -1,288,000,000 -83,000,000 -568,000,000 285,000,000 
      derivatives
    		932,000,000 -254,000,000 -1,336,000,000 -289,000,000 307,000,000 267,000,000 -404,000,000 21,000,000 -354,000,000 -2,068,000,000 1,388,000,000 699,000,000 -3,000,000,000 467,000,000 573,000,000 
      other
    		-1,599,000,000 -767,000,000 -2,358,000,000 -2,215,000,000 -1,516,000,000 -1,240,000,000 -578,000,000 -665,000,000 -1,876,000,000 -422,000,000 454,000,000 -1,476,000,000 617,000,000 -209,000,000 -19,000,000 
      cash flows from (used in) operating activities
    		4,296,000,000 1,162,000,000 -2,506,000,000 1,105,000,000 -146,000,000 5,221,000,000 2,840,000,000 1,224,000,000 1,343,000,000 -622,000,000 4,278,000,000 1,501,000,000 1,000,000 3,333,000,000 5,417,000,000 
      cash flows from investing activities
    		               
      proceeds from the sale/maturity/prepayment of:
    		               
      fixed maturities, available-for-sale
    		10,413,000,000 9,340,000,000 10,959,000,000 14,938,000,000 14,107,000,000 10,794,000,000 10,509,000,000 11,056,000,000 11,178,000,000 11,972,000,000 10,215,000,000 14,396,000,000 14,240,000,000 15,809,000,000 14,037,000,000 
      fixed maturities, trading
    		1,445,000,000 322,000,000 1,123,000,000 606,000,000 1,328,000,000 570,000,000 518,000,000 118,000,000 226,000,000 220,000,000 215,000,000 676,000,000 530,000,000 1,269,000,000 216,000,000 
      assets supporting experience-rated contractholder liabilities
    		360,000,000 247,000,000 486,000,000 428,000,000 383,000,000 361,000,000 437,000,000 491,000,000 765,000,000 399,000,000 776,000,000 742,000,000 9,493,000,000 4,985,000,000 4,830,000,000 
      equity securities
    		883,000,000 2,277,000,000 2,344,000,000 1,435,000,000 826,000,000 2,266,000,000 2,045,000,000 642,000,000 550,000,000 627,000,000 535,000,000 991,000,000 1,544,000,000 827,000,000 1,197,000,000 
      commercial mortgage and other loans
    		1,739,000,000 1,715,000,000 1,947,000,000 899,000,000 1,349,000,000 1,339,000,000 1,037,000,000 830,000,000 855,000,000 1,286,000,000 1,290,000,000 1,667,000,000 1,337,000,000 3,861,000,000 1,767,000,000 
      policy loans
    		431,000,000 495,000,000 461,000,000 462,000,000 592,000,000 438,000,000 439,000,000 420,000,000 460,000,000 460,000,000 409,000,000 399,000,000 470,000,000 428,000,000 500,000,000 
      other invested assets
    		573,000,000 643,000,000 876,000,000 575,000,000 297,000,000 511,000,000 265,000,000 283,000,000 249,000,000 362,000,000 272,000,000 674,000,000 481,000,000 821,000,000 832,000,000 
      short-term investments
    		9,942,000,000 8,374,000,000 5,258,000,000 7,152,000,000 8,006,000,000 7,937,000,000 9,132,000,000 8,684,000,000 6,381,000,000 10,534,000,000 9,503,000,000 10,130,000,000 10,486,000,000 8,004,000,000 8,694,000,000 
      payments for the purchase/origination of:
    		               
      cash flows from (used in) investing activities
    		-9,242,000,000 -5,828,000,000 -5,465,000,000 -5,700,000,000 -5,340,000,000 -10,244,000,000 -2,881,000,000 -2,840,000,000 -3,303,000,000 -3,376,000,000 -1,022,000,000 -3,735,000,000 495,000,000 -5,939,000,000 -2,565,000,000 
      cash flows from financing activities
    		               
      policyholders’ account deposits
    		10,407,000,000 10,947,000,000 8,993,000,000 10,126,000,000 8,962,000,000 8,569,000,000 7,288,000,000 6,655,000,000 6,747,000,000 7,986,000,000 8,139,000,000 5,989,000,000 7,980,000,000 8,213,000,000 8,400,000,000 
      policyholders’ account withdrawals
    		-5,433,000,000 -4,846,000,000 -4,600,000,000 -4,681,000,000 -4,825,000,000 -4,664,000,000 -4,855,000,000 -4,199,000,000 -4,592,000,000 -5,937,000,000 -5,448,000,000 -5,515,000,000 -7,249,000,000 -7,096,000,000 -6,556,000,000 
      net change in securities sold under agreements to repurchase and cash collateral for loaned securities
    		1,162,000,000 316,000,000 639,000,000 1,948,000,000 437,000,000 1,008,000,000 309,000,000 -1,287,000,000 -97,000,000 -1,399,000,000 341,000,000 -109,000,000 -374,000,000 152,000,000 295,000,000 
      cash dividends paid on common stock
    		-479,000,000 -481,000,000 -491,000,000 -469,000,000 -472,000,000 -483,000,000 -458,000,000 -460,000,000 -473,000,000 -446,000,000 -450,000,000 -455,000,000 -466,000,000 -440,000,000 -448,000,000 
      net change in financing arrangements
    		395,000,000 -110,000,000 266,000,000 -40,000,000 15,000,000 -511,000,000 -80,000,000 -35,000,000 38,000,000 31,000,000 13,000,000 -263,000,000 5,000,000 189,000,000 35,000,000 
      common stock acquired
    		-250,000,000 -250,000,000 -246,000,000 -253,000,000 -251,000,000 -242,000,000 -250,000,000 -253,000,000 -251,000,000 -375,000,000 -375,000,000 -374,000,000 -364,000,000 -403,000,000 -859,000,000 
      common stock reissued for exercise of stock options
    		27,000,000 29,000,000 28,000,000 49,000,000 46,000,000 47,000,000 28,000,000 35,000,000 28,000,000 35,000,000 29,000,000 30,000,000 69,000,000 50,000,000 37,000,000 
      proceeds from the issuance of debt
    		161,000,000 69,000,000 841,000,000 145,000,000 139,000,000 1,019,000,000 167,000,000 0 495,000,000 168,000,000 1,514,000,000 0 1,024,000,000 195,000,000 2,000,000 
      repayments of debt
    		-352,000,000 -1,003,000,000 -191,000,000 -62,000,000 -211,000,000 -539,000,000 -344,000,000 -1,575,000,000 -29,000,000 -3,000,000 -1,057,000,000 -64,000,000 -60,000,000 -541,000,000 -994,000,000 
      proceeds from notes issued by consolidated vies
    		304,000,000 185,000,000 7,000,000 641,000,000 23,000,000 159,000,000 417,000,000 8,000,000 59,000,000       
      repayments of notes issued by consolidated vies
    		-187,000,000 0 0 -392,000,000 0 -1,000,000 -21,000,000 -2,000,000 -16,000,000     0 0 
      cash flows from (used in) financing activities
    		5,727,000,000 5,149,000,000 5,499,000,000 7,429,000,000 4,002,000,000 4,543,000,000 2,353,000,000 -1,015,000,000 2,129,000,000 858,000,000 2,611,000,000 1,038,000,000 426,000,000 516,000,000 -860,000,000 
      effect of foreign exchange rate changes on cash balances
    		42,000,000 114,000,000 56,000,000 263,000,000 -141,000,000 -227,000,000 -77,000,000 -148,000,000 5,000,000 287,000,000 -129,000,000 -231,000,000 -86,000,000 -57,000,000 -35,000,000 
      net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
    		823,000,000 597,000,000 -2,416,000,000 3,097,000,000 -1,625,000,000 -707,000,000 2,235,000,000 -2,779,000,000 174,000,000 -2,853,000,000 5,738,000,000 278,000,000 1,202,000,000 -2,719,000,000 458,000,000 
      cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of year
    		0 0 18,520,000,000 0 0 19,463,000,000 0 0 17,299,000,000 0 0 0 12,934,000,000 0 0 
      cash, cash equivalents, restricted cash and restricted cash equivalents, end of period
    		823,000,000 597,000,000 16,104,000,000 3,097,000,000 -1,625,000,000 18,756,000,000 2,235,000,000 -2,779,000,000 17,473,000,000  5,738,000,000 278,000,000 14,136,000,000  458,000,000 
      fixed maturities, held-to-maturity
    		   0 0 0 5,000,000 10,000,000 7,000,000 14,000,000 7,000,000 8,000,000 9,000,000 84,000,000 11,000,000 
      dispositions, net of cash disposed
    		      0   0 0   0 0 
      net increase in cash, cash equivalents, restricted cash and restricted cash equivalents including balances classified as held-for-sale
    		      2,235,000,000 -2,779,000,000 174,000,000 -2,853,000,000 5,738,000,000 -1,427,000,000 836,000,000 -2,147,000,000  
      net change in cash balances classified as held-for-sale
    		      0 0 0 0 0 -1,705,000,000 -366,000,000 572,000,000  
      goodwill impairment
    		               
      cash, cash equivalents, restricted cash and restricted cash equivalents, end of year
    		               
      acquisitions, net of cash acquired
    		               
      non-cash transactions during the period
    		               
      treasury stock shares issued for stock-based compensation programs
    		               
      significant pension risk transfer transactions:
    		               
      assets received, excluding cash and cash equivalents
    		               
      liabilities assumed
    		               
      net cash received
    		               
      reconciliation to the unaudited interim consolidated statements of financial position
    		               
      cash and cash equivalents
    		               
      restricted cash and restricted cash equivalents
    		               
      total cash, cash equivalents, restricted cash and restricted cash equivalents
    		               
      conversion of surplus notes into common stock
    		               
      net increase in cash, cash equivalents restricted cash and restricted cash equivalents
    		               
      cash, cash equivalents restricted cash and restricted cash equivalents, beginning of year
    		               
      cash, cash equivalents restricted cash and restricted cash equivalents, end of period
    		               
      reconciliation to statement of financial position
    		               
      total cash, cash equivalents restricted cash and restricted cash equivalents
    		               
      acquisition of business, net of cash acquired
    		               
      net increase in cash, cash equivalents restricted cash and restricted cash equivalent
    		               
      cash, cash equivalents restricted cash and restricted cash equivalent, beginning of year
    		               
      cash, cash equivalents restricted cash and restricted cash equivalent, end of period
    		               
      acquisition:
    		               
      assets acquired, excluding cash and cash equivalents
    		               
      net cash paid on acquisition
    		               
      (gains) losses on trading account assets supporting insurance liabilities
    		               
      trading account assets supporting insurance liabilities and other trading account assets
    		               
      equity securities, available-for-sale
    		               
      other long-term investments
    		               
      class b stock acquired
    		               
      excess tax benefits from share-based payment arrangements
    		               
      net increase in cash and cash equivalents
    		               
      cash and cash equivalents, beginning of year
    		               
      cash and cash equivalents, end of period
    		               
      other trading account assets
    		               
      assets acquired, excluding cash and cash equivalents acquired
    		               
      net cash paid
    		               
      cash dividends paid on class b stock
    		               
      acquisition of business, net of cash acquired.
    		               
      gains on trading account assets supporting insurance liabilities
    		               
      acquisition of gibraltar bsn life berhad:
    		               
      noncontrolling interest assumed
    		               
      cash flows used in investing activities
    		               
      acquisition of gibraltar bsn life berhad
    		               
      acquisition of the hartford’s individual life business
    		               
      net decrease in cash and cash equivalents
    		               
      acquisition of uniasia life assurance berhad
    		               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.